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 Stroke becomes a significant problem for developing countries. In Indonesia 
the data show its incidences 234 per 100.000 people, and around 2 - 8 % 
stroke patients experiencing cerebrovascular session will get neurophaty 
pain. It happens because of sensoric deviation after stroke, so the brain does 
not completely send information to the body correctly. Patients experiencing 
neurophaty pain are able to face decreasing living quality as the effect of 
long term painful disturbance. Therefore, it is important to maintain the 
patients’ living quality. The aim of the study is to investigate the comparison 
of using gabapentin and amitriptilin toward living quality of ischemic stroke 
patients with neurophaty pain in the hospitals in Jogja. The method used in 
this study was quasi experimental with consequtive sampling. The study was 
conducted on 22nd of April-31st of Juli 2013 by involving 23 patients in 
gabapentin group and 18 patientsin amitriptilin group that would be 
evaluated during 1 month. Living quality was assessed by Brief Pain 
Inventory (BPI) in week 0 and week 4. The result of the study showed that 
the use of gabapentin and amitriptilin in 4 weeks showed the increase of 
living quality represented by decreasing the score based on BPI questioner 
1.67±0.78 and 1.37±0.80 with p-value>0.05 meaning that there was no 
significant difference. It can be concluded the comparison of using 
gabapentin and amitriptilin in post ischemic stroke patient with neuropathy 
pain not significantly increase the quality of in the hospitals in Jogja. 
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1. INTRODUCTION  
Stroke becomes a problem in developing countries. According to WHO, there are 15 million 
populations get stroke attack every year in the whole of the world, and the most common patients are 
elderlies with death rate every 10years between 55 and  85 year old [1].   
Based on a survey in Bogor, the data in the developing countries like Indonesia showed its 
incidences of 234 per 100.000 people. According to the data of Riskesdas Depkes RI (2007) in its national 
report, it was mentioned that the main death cause for all ages was stroke (15,4%), TB (7,5%), and 
hipertension (6,8%) [2]. 
Medical treatment for post stroke pain in Indonesia has been started to use medicine from the group 
of tricyclic anti-depresant like amiriptilin and from the group of anti-convulsanlike gabapentin. Patients’ 
response that used both medicines was good enough. Here they are some Evidence Based Medicine (EBM) 
studies of amiriptilin and gabapentin medicine used as pain relief medicine: 
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1. The research conducted by Lamphlet al (2002) showed the result in placebo group having pain level 21% 
and 17% in profilaksis group with amitriptilin in 1 year after the diagnosis of post stroke pain [3].  
2. A research done by Ter Ong et al (2003) mentioned that between 1998 and 2001 with 684 patients, in 
which 52 of them were in the main age of 58 years old, participated in two stages reserach. The first 
stage, tehreseracher examined the patients without any special treatment for parestesia. The patients were 
only given antiplatelet orantikoagulan medicine during 6 month. During the second stage, the patients (44 
patients) got amitriptilintheraphy, and the result showed that 14 patients (31.8%) reported that they did 
not experience parestesia. The data shows that amitriptilin can be used in post stroke paresthesia 
management [4]. 
3. A research done by Attal N et al (1998) mentioned that the effect of gabapentin with low dose, and if it 
was increased frequently until its maximum 2.400 mg/ day showing that gabapentin had the effect of 
antiallodiniaandantihiperalgesia. Although there was side effect, it was only the light one. And it does not 
disturb the patients’ daily activities [5].  
The explanation above shows that gabapentin andamitriptilincould be used as pain killer for 
neurophaty pain although both of the medicines were not mentioned in the medicine indication on the 
medicine leaphlet. The patients having post stroke neurophaty pain can cause the decrease of patients’ living 
quality because they experienced long term pain disturbance, so it had significant effect to the patients’ mood 
condition, sleeping quality, and daily activities. Thus, it is important to measure the intencity, pain quality, 
and abnormal sensation. The measurement of living quality becomes a significant factor in the outcome of 
stroke theraphy because based on jaraczk & kozubski (2003), It is shown the research result that the change 
of living quality is clearly seen to the patients after getting stroke [6], but there are still very few researches 
which focus on living quality of the patients especially the pain of post stroke and on both medicines. 
Therefore, measurement is needed whether both medicines can give significant influence of the patients’ 
living quality after stroke, so there should be fuether research investigating the patients’ living quality after 
stroke the period before and after using both medicines. 
Choosing a hospital in Jogja was significant because this hospital was one of the government 
hospitals type B which had some facilities such as neuro outpatient department with patients visit aroud 800-
1000 patients per month. Stroke patients visitation was in the first highest rate in 1 month. Jogja Hospital was 
an educational hospital supporting the research, so it was easier for the researcher to take the data there. 
 
 
2. RESEARCH METHOD 
The research is an experimental study with QuasyEksperimental Design framework conducted to 
ischemic stroke patients having post stroke pain coming to neuro-pily in the hospitals in Jogja during 22nd of 
April-31st of July 2013. 
 
2.1. Material 
The research uses primary data in the form of questioner as the media to collect the data. Questioner 
used was in the form of Brief Pain Inventory in English translated to Bahasa Indonesia. The questioner had 
been tested for its validity and reliability.  
 
2.2. Research Process 
The research was conducted within these following steps: 
1. Preparation step 
This step includes finishing etichal clearanceof the research and permission from the hospitals as the 
places for the research as well as the preparation of report sheets of the patients’ medical record and 
questioners.  
2. Research Steps 
The research was conducted in several forms of activities, such as: 
a. The patients who were diagnosed by the doctors clinically having post ischemic stroke in the Hospital 
in Jogja were given informed consent. Initial examination was given single amitriptilin treatment and 
single gabapentin, and the patients’ living quality was assessed by using Brief Pain Inventory 
questioner. In the end, the patients got 1 month treatment, and ther living quality was re-assessed 
again.  
b. Questioner filling was guided directly by the researcher, so the resepondents could ask some questions 
if they did not understand the materials. After that, the researcher rechecked after the questioners were 
returned by the respondents. In the questioner of BPI, there were 1-10 scales in which score 1 was 
used for the definition not to disturb, and score 10 for disturbing definition, so the questioner has the 
lowest score having the best living quality.  
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3. Data Processing and Data Analysis 
The data from the patients and the data from the questioners were processed and analyzed based on its 
analysis method used.  
 
2.3. Data Proccesing and Analysis  
Research data were processed within these following steps as follow:  
1. Descriptive analisys from the characteristic of research subject (based on gender). 
2. The Test analysis of Brief Pain Inventory questioner significance was conducted by using a statistical 
method namely student t-testwith the rate of trust 95. 
 
 
3. RESULTS AND ANALYSIS  
The research was conducted on 22nd of April until 31st of July 2013 by using consecutive sampling. 
The patients were patients of ischemic post stroke 57 patients. The patients were allocated into 2 groups: 
gabapentin group (n=31) and amitriptilin group (n=26). During the research, there were 16 patients who did 
not continue/stopped from the research consisting of 8 patients from gabapentin and 8 patients from 
amitriptilin because of double teraphy, side effect of the medicine and the unclear address and phone number, 
so it was difficult to reach them. Here they were the patients’ characteristics following the research until the 
end of the processthat is shown in Table 1. 
 
 
Table1.The Characteristic of Patients Demographic Following the Research in the Hospitals in Jogja. 
Respondent Characteristic Gabapentin Amitriptilin Value N % N % 
Gender      
 Male 16 69.6 8 44.4 0.105  Female 7 30.4 10 55.6 
Age      
 < 40 years old 0 0 1 5.6 
0.436  40 years old – 60 years old 10 43.5 9 50 
 >60 years old 13 42.5 8 44.4 
Education       
 Elemteary School 7 30.4 9 50 
0.283  Junior High School 4 17.4 5 27.8  Senior High School 9 39.1 3 16.6 
 Diploma 3 13.1 1 5.6 
Job      
 Unemployment 17 74 12 66.7 
0.151  Enterpreneur 3 13 6 33.3 
 Private Sector 3 13 0 0 
 
 
The characteristic of the research subject was grouped into several categories such as gender, age, 
education background, and job. The result of statistical analysis using chi squaretest got the result 
respectively p value >0.05 they were 0.105; 0.436; 0.283; 0.151. It shows that there was no significant 
difference in every characteritis of the research subject, so it could be concluded that the subjects of the 
research were homogenous. 
Neurophaty pain can cause the decrease of living quality to the patients, so it is significant to have a 
research to investigate the image of patients’ living quality after stroke syndrome. It is similar to what was 
written by NICE (2010) mentioning that living quality needs to be measured because neurophatic pain can 
have significant effect to people’s living quality [7]. This research used Brief Pain Inventory questioner, in 
which questioner was able to represent: general activities, mood situation, walking capability, usual chores, 
relationship with other people, and the way to enjoy life.This questioner has lowest score which means to 
have the best living quality. The processing data of the questioner result score used t-test with trust rate 95% 
by comparing the mean rate of patients’ living quality. 
Measurment of living quality value used score with 0-10 scales in which score 0 meaning that it did 
not disturb, and score 10 was very disturbing, so the less the score, the better living quality the patients 
have.The result of this research also shows that both gabapentin group and amitriptilin group show living 
quality decrease if it was compared before and after the theraphy. The result of the analysis is presented in 
Table 2. 
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Table 2. Mean Score of Living Quality of Patients with PostNyeriPain in the Initial Condition 
Description 
Gabapentin Group 
(mean±SD) 
Amitriptilin Group 
(mean±SD) 
Week O Week 4 p-value Week O Week 4 p-value 
Daily Activities 4.83±2.19 3.00±1.76 *0.00 4.50±1.98 2.94±1.69 0.00 
Mood Situation 3.91±1.99 2.35±1.27 0.00 4.22±2.24 2.44±1.19 *0.00 
Walking Ability 5.22±2.09 3.17±1.59 0.00 3.11±2.35 2.00±1.41 0.00 
Daily Chores 4.78±2.11 3.13±1.71 0.00 4.22±1.96 2.89±1.75 *0.00 
Relationship with 
Others 4.43±2.15 2.91±1.62 *0.00 3.06±1.79 1.89±0.83 0.00 
Sleeping Quality 3.30±2.64 1.83±1.80 0.00 3.33±2.47 2.06±1.66 0.00 
Enjoying Life 4.13±1.91 2.52±1.41 *0.00 3.50±2.04 2.17±1.25 *0.00 
Whole Living 
Quality 26.49±11.08 16.39±8.14 *0.00 22.44±9.85 14.22±6.98 *0.00 
Mean Value of 
Living Quality 4.37±1.82 2.70±1.34 *0.00 3.71±1.64 2.34±1.14 *0.00 
*independent test result of t-test 
 
 
Based on the Table 2, it can be known that the mean score of initial whole living quality in 
gabapentin group got 4.37±1.82. After getting 1 month theraphy, they were re-measured,and the result was 
2.70±1.34. Systematically there was decrease 1.67 strengthening by paired sample t-test which got p-value 
0.00(p<0.05) meaning that it was statistically different (significant), while amitriptilin group got 
3.71±1.64.After getting the theraphy for 1, the patients were re-examined, and the result got was 2.34±1.14. 
Systematically, there was decrease 1.37 strengthening by paired sample t-test (normal data distributed) 
getting p-value 0.00(p<0.05). It means that it was statistically different (significant).  
The explanation above shows that the use of gabapentin andamitriptilin can increase the patients’ 
living quality shown by the decrease of BPI score.There is also the examination of pain intencity, and there 
was decrease of pain scale by using VAS scale 2.87±1.33 for gabapentin group, and 2.44±0.78 for 
amitriptilin group in 1 month. Pain intencity could also affect the patients’ living quality because the patients 
do not experience long term pain disturbance, so the patients would feel more comfortable to the disease they 
had. The idea is similar to Smith (2012) mentioning that patients with neurophaty pain can increase their 
living quality if they have good living management [8]. Connor (2009) also mentions that the repairment of 
living quality is strongly correlated to the increase of living quality [9].  
In addition, the comparison of using amitriptilin and gabapentin as a neurophaty pain therapy of post 
stroke is not included in the list of medicine leaphet, so the use still becomes off label use because there were 
not enough researches that supported the effectivity of both medicines in pain management of post stroke 
neurophaty. So far there are two Randomized Control Trial investigating the comparison of the theraphy 
effect of gabapentin and amitriptilin; those are Diabetic Peripheral Neurophaty Pain (DPN) (Morello et. al., 
1999) and Spinal Cord Injury (Rintala et. al., 2007) [10], [11]. The result of Morello’s research (1999) 
reported that 52% (11 of 21) patients got gabapentin cure (daily dosage 1.565 mg) and 67% (14 of 21) with 
amitriptilin (daily dosage 59 mg). The research shows that the cure of both medicines candecreasase pain 
intencity, but it could not reflect the comparison effectivity between gabapentin and amitriptilin.   
In this research, the investigation was seen from the difference of the initial and the end mean score 
of the patients’ living quality, and those two groups were compared. The objective was to see from which 
group that was able to repair the patients’ living quality after stroke. Based on the table 3 it can be known that 
the whole living quality of the patients got Mean result±SD. Systematically, gabapentin group was better 
than amitriptilin group. However, after they were tested by using independent t-test sample (normal 
distribution), significance score was p>0,05 meaning that in this research the change of living quality of 
gabapentin group and amitriptilin group was not significantly different statistically (not significant).The 
result of the analysis is presented in Table 3. 
 
Table3. Mean Score of Living Quality Difference of Post Stroke Pain Patients 
Explanation Gabapentin Group (mean±SD) 
Amitriptilin Group 
(mean±SD) p-value 
Daily Activities 1.83±1.23 1.56±0.98 0.53 
Mood Condition 1.57±1.16 1.78±1.35 0.71 
Walking Ability  2.04±1.43 1.11±1.23 0.03 
Usual Chore 1.65±1.07 1.33±0.97 0.34 
Relationship with Other People 1.52±1.08 1.17±1.25 0.18 
Sleeping Quality 1.48±1.38 1.28±1.23 0.66 
Enjoying Life 1.61±0.89 1.33±1.09 0.15 
Whole Living Quality* 10.87±4.90 8.22±4.81 0.22 
Mean Value of Difference Living Quality 1.67±0.78 1.37±0.80 0.22 
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Stroke patients experienced brain sensoric damage, stiff joint/paralyse which can cause pain and 
strange sensation that is usually called as central stroke pain orcentral pain syndrome (CPS). CPS was 
caused by the damage of the area in the thalamus. The pain was the mixture of the feeling of hot, cold, burnt, 
painful, and numb. That kind of feeling can influence the patients’ living quality. Some of the patients 
complained that the feeling would get worse with the movement difference and cold temperature (before the 
dawn and twilight). From the research result, there was difference after conducting 1 month teraphy both 
from gabapentin group and from amitriptilin. The patients were capable to do their daily activities better, 
having more comfortable mood feeling, better walking activity, able to have outdoor cativities, so their 
relationship with other people could be maintained. They were able to have better sleep and enjoy their life 
better. The reference of researches about living quality of post stroke patients using gabapentin and 
amitriptilin medicines as pain theraphy is very limited. This research is similar to Nurwahyuni research 
(1999) entitled Living Quality of Port Stroke Patients Based on Lesi and Stroke Kind. In this research, 39.13 
patients caould have good living quality by assessing their answr using Euro Qol questioner [12]. 
In this research, the researcher also investigated the side effect of using gabapentin and amitriptilin. In 
gabapentin group, the highest rate of the side effect is sleepiness (16.1%), while for amitriptilin the highest 
rate was sleepiness (19.2%), weak (11.5%), and dry mouth (7.7%). The result is similar to a previous 
research by Backonjaet. al. (1998) reporting that the main side effect of using gabapentin was headache 
(24%) and sleepiness (23%) [13], while the side effect that is often reported in the use of amitriptilin is 
sleepiness and anticolinergic effect (dry mouth and constipation). Gabapentin group and amitriptilin group 
had the same number of the patients 11 patients getting the side effect of the medicine, but after it was 
divided with the total patients in the group, there was 42.2% to the group of amitriptilin and 35.3% in the 
group of gabapentin. From the explanation above, gabapentin had good, secure tolerability, and less 
interacted with other medicines compared to the other painkillers [14]. 
Based on the investigation and research data got from gabapentin and amitriptilin group, it could be 
concluded that those medicines have similar influence to the patients’ living quality, so it is expected that 
both medicines can be re-included as the List and Plafon of Medicine Price as neuron theraphy, or in 2014, 
all Indonesian people can get health insurance, so both medicines can be included in insurance medicine list. 
It is not only for patients with Diabetec Periperal Neuropathy and Post Herpetic Neuralgia. Besides, living 
quality should become a main consideration in the aspect of cost and side effect. From the aspect of cost, 
amitriptilin was cheaper that gabapentin, but the efication and side effect should be considered too. In the 
literature, the side effect of amitriptilin medicine can be avoided to the elderly, but based on the demographic 
data patients with >60 were quite high.In the literature, the side effect of amitriptilin is avoided in elderly, 
which is based on Morello’s research (1999), and Lacy et. al. (2002) reported that it has side effect risk on 
cardiovascular system and extrapirimidal system [10],[15], however from the demographic data that could be 
achieved, patients with the age >60 was quite high. 
 
 
4. CONCLUSION  
Both using gabapentin and amitriptilin treatment during 4 weeks showed increasing of living quality 
in every group, but the comparison of them was not significantly different. That means the comparison of 
using gabapentin and amitriptilin in post ischemic stroke patient with neuropathy pain not significantly 
increase the quality of in the hospitals in Jogja. 
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